$4.51
1.31%
Nasdaq, Sep 24, 04:00 pm EDT. Closed.
ISIN
US18914F1030
Symbol
CLOV

Clover Health Investments Corp - Ordinary Shares - Class A Target price 2026 - Analyst rating & recommendation

Clover Health Investments Corp - Ordinary Shares - Class A Classifications & Recommendation

Buy
60%
Hold
40%

Clover Health Investments Corp - Ordinary Shares - Class A Price Target

Target Price $5.10
Price $4.51
Potential
Number of Estimates 6
6 Analysts have issued a price target Clover Health Investments Corp - Ordinary Shares - Class A 2027 . The average Clover Health Investments Corp - Ordinary Shares - Class A target price is $5.10. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 10 analysts: 6 Analysts recommend Clover Health Investments Corp - Ordinary Shares - Class A to buy, 4 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Clover Health Investments Corp - Ordinary Shares - Class A stock has an average upside potential 2027 of . Most analysts recommend the Clover Health Investments Corp - Ordinary Shares - Class A stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2030

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Billion $ 1.92 3.01
40.34% 56.58%
EBITDA Margin -4.36% 2.67%
35.37% 161.28%
Net Margin -4.45% 1.02%
41.73% 122.94%

6 Analysts have issued a sales forecast Clover Health Investments Corp - Ordinary Shares - Class A 2026 . The average Clover Health Investments Corp - Ordinary Shares - Class A sales estimate is

$3.0b
unlock
. This is
21.65% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$3.1b 25.69%
unlock
, the lowest is
$2.9b 16.28%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $1.9b 40.34%
2026
$3.0b 56.58%
unlock
2027
$3.6b 19.65%
unlock
2028
$4.0b 11.51%
unlock
2029
$4.4b 10.60%
unlock
2030
$4.9b 10.19%
unlock

5 Analysts have issued an Clover Health Investments Corp - Ordinary Shares - Class A EBITDA forecast 2026. The average Clover Health Investments Corp - Ordinary Shares - Class A EBITDA estimate is

$80.4m
unlock
. This is
588.36% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$83.6m 607.78%
unlock
, the lowest is
$76.2m 562.85%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $-83.8m 89.98%
2026
$80.4m 195.88%
unlock
2027
$101m 25.63%
unlock
2028
$134m 32.40%
unlock
2029
$188m 40.89%
unlock
2030
$258m 36.93%
unlock

EBITDA Margin

2025 -4.36% 35.37%
2026
2.67% 161.28%
unlock
2027
2.80% 4.87%
unlock
2028
3.33% 18.93%
unlock
2029
4.24% 27.33%
unlock
2030
5.27% 24.29%
unlock

5 Clover Health Investments Corp - Ordinary Shares - Class A Analysts have issued a net profit forecast 2026. The average Clover Health Investments Corp - Ordinary Shares - Class A net profit estimate is

$30.6m
unlock
. This is
266.61% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$33.3m 281.59%
unlock
, the lowest is
$25.9m 241.23%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $-85.6m 98.91%
2026
$30.6m 135.76%
unlock
2027
$43.2m 41.16%
unlock
2028
$64.8m 50.00%
unlock
2029
$151m 133.33%
unlock
2030
$211m 39.28%
unlock

Net Margin

2025 -4.45% 41.73%
2026
1.02% 122.94%
unlock
2027
1.20% 17.65%
unlock
2028
1.61% 34.17%
unlock
2029
3.40% 111.18%
unlock
2030
4.30% 26.47%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ -0.17 0.06
88.89% 135.29%
P/E 78.02
EV/Sales 0.71

5 Analysts have issued a Clover Health Investments Corp - Ordinary Shares - Class A forecast for earnings per share. The average Clover Health Investments Corp - Ordinary Shares - Class A EPS is

$0.06
unlock
. This is
250.00% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$0.06 250.00%
unlock
, the lowest is
$0.05 225.00%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $-0.17 88.89%
2026
$0.06 135.29%
unlock
2027
$0.08 33.33%
unlock
2028
$0.12 50.00%
unlock
2029
$0.29 141.67%
unlock
2030
$0.40 37.93%
unlock

P/E ratio

Current -112.75 197.69%
2026
78.02 169.20%
unlock
2027
55.27 29.16%
unlock
2028
36.85 33.33%
unlock
2029
15.79 57.15%
unlock
2030
11.34 28.18%
unlock

Based on analysts' sales estimates for 2026, the Clover Health Investments Corp - Ordinary Shares - Class A stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.87 3.57%
2026
0.71 17.89%
unlock
2027
0.60 16.42%
unlock
2028
0.54 10.33%
unlock
2029
0.48 9.58%
unlock
2030
0.44 9.23%
unlock

P/S ratio

Current 0.97 0.14%
2026
0.80 17.79%
unlock
2027
0.66 16.43%
unlock
2028
0.60 10.32%
unlock
2029
0.54 9.58%
unlock
2030
0.49 9.24%
unlock

Clover Health Investments Corp - Ordinary Shares - Class A...

Current Clover Health Investments Corp - Ordinary Shares - Class A Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
UBS
Locked
➜
Locked
Locked Aug 06 2026
Canaccord Genuity
Locked
➜
Locked
Locked Jul 21 2026
UBS
Locked
➜
Locked
Locked Jun 11 2026
Canaccord Genuity
Locked
➜
Locked
Locked Jun 04 2026
Canaccord Genuity
Locked
➜
Locked
Locked Mar 20 2026
Leerink Partners
Locked
➜
Locked
Locked Mar 05 2026
Canaccord Genuity
Locked
➜
Locked
Locked Jan 20 2026
Analyst Rating Date
Locked
UBS:
Locked
➜
Locked
Aug 06 2026
Locked
Canaccord Genuity:
Locked
➜
Locked
Jul 21 2026
Locked
UBS:
Locked
➜
Locked
Jun 11 2026
Locked
Canaccord Genuity:
Locked
➜
Locked
Jun 04 2026
Locked
Canaccord Genuity:
Locked
➜
Locked
Mar 20 2026
Locked
Leerink Partners:
Locked
➜
Locked
Mar 05 2026
Locked
Canaccord Genuity:
Locked
➜
Locked
Jan 20 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today